Artificial intelligence is moving from experimentation to execution in clinical research. The opportunity is to use AI, machine learning and NLP to im...
A case study in managing 40 sites, nearly 600 randomized subjects and complex clinical endpoints across multiple geographies Complex ophthalmology tri...
pharmaREADY 2026: Building the Future of Regulatory Operations with AI, eCTD 4.0 and Connected Technology From regulatory publishing to intelligent, c...
FDA’s New Draft Guidance on Container Closure Systems: What Drug Developers Need to Know A risk-based approach puts packaging suitability, comp...
From diabetes management to obesity, cardiovascular risk and emerging metabolic indications, GLP-1 therapies are changing what sponsors expect from cl...
What pharmaceutical companies in India need to know about Schedule M, inspection readiness and building an effective pharmacovigilance system On 3 Jun...
The U.S. biopharmaceutical industry is entering a new phase of innovation, one shaped by increasing R&D costs, impending patent expirations and th...
Five Mistakes Companies Make During eCTD 4.0 Implementation And How to Avoid Them The regulatory landscape is entering one of its most significant per...
Meet Navitas Life Sciences at Pharmacovigilance India 2026 As the pharmaceutical industry embraces artificial intelligence, real-world evidence and in...
Drug development begins with one fundamental question: How does the body handle a drug and how does the drug affect the body?The answer comes from pha...
Boutique by Design. Outcome-focused by Model. As clinical trials become increasingly complex, sponsors need more than functional support, they need ex...
How biotech companies can identify the right CRO partner to accelerate patient recruitment, improve trial quality, reduce operational burden and deliv...
Pharmaceutical organizations are facing a new challenge that goes beyond clinical development, pharmacovigilance and regulatory submissions: controlli...
Bringing a new therapy to market is one of the most significant milestones in a pharmaceutical or biotechnology company's journey. Yet, while organiza...
Biotech and pharma companies face increasing pressure to accelerate timelines, manage costs, cater to regulatory changes and maintain quality across g...
Scientific breakthroughs in oncology, rare diseases, cell and gene therapies, immunology and precision medicine are increasingly being driven by agile...
25 Years in 25 Voices of Peer Leadership For 25 years, the forums and peer networks powered by Navitas Life Sciences have brought together pharmaceuti...
How Foundations, Biotech and Pharma Organizations Can Accelerate Parkinson’s Studies with the Right Clinical Research Partner Parkinson’...
How integrated clinical, regulatory, pharmacovigilance and data science ecosystems are accelerating global development programs Insights ahead of the ...
Selecting the right clinical research organization (CRO) can determine the success or failure of a biotech company’s clinical program. With inc...